Research

Engineering

Business Development

Arts and Design

Accounting

Product Management

Operations

Information Technology

Human Resources

Healthcare Services

Finance

AI-driven drug discovery and development platform

Chief Executive Officer & President | Member, Board of Directors

Chief Technology Officer

Digital Education Market worth $115.39 billion by 2031 - Report by MarketsandMarkets™

AI in Protein Engineering Market worth $3.82 billion by 2031 - Exclusive Report by MarketsandMarkets™

An Open Door and Patient Capital: Utah's Plan to Turn Research Into Startups

AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment

Vice President, Business Development and Licensing

Recursion is a clinical-stage TechBio company reimagining drug discovery through an AI-native platform spanning biology, chemistry, and clinical development. The Vice President will lead business development and licensing for Recursion’s molecule portfolio, identifying and evaluating partnerships, structuring and negotiating transactions, and aligning cross-functional teams to drive portfolio value.

Associate Director, Computational Biology – Early Discovery

Recursion is a clinical-stage TechBio company focused on improving lives through advanced drug discovery. The Associate Director of Computational Biology will lead a team to innovate in drug discovery, focusing on oncology targets and therapeutics while collaborating with cross-functional teams to drive impactful data analyses and strategies.

Senior AI Researcher

Recursion is a clinical-stage TechBio company using AI to decode biology and improve lives through drug discovery and development. The Senior AI Researcher will join a cross-functional team to advance AI-powered drug discovery and develop scalable biomedical research and end-to-end applications across discovery, design, and translation.